Meet the team
Meet
Sonia Houghton
Sonia is our dedicated Controlled Environment Storage Business Manager at Biofortuna. With a wealth of experience in optimising storage solutions and a keen eye for precision, Sonia ensures that our sample storage systems maintain the highest standards of stability and reliability. Her expertise is crucial in delivering tailored storage solutions that meet the unique needs of our customers.
Read on to discover what she enjoys most about her role and her plans for the future.

Hi Sonia, tell us a little about yourself.
Hi, I’m Sonia, I’m a research scientist by training and whilst I believe I can hold my own in the lab, I much prefer working in the background to facilitate scientific endeavour, which is why I gravitated to the service industry.
Tell us about your role at Biofortuna?
Previously, I was the CEO and co-founder of Cryoniss, a specialist temperature-controlled storage company providing access to world-class capabilities for the storage of biological samples and products from controlled ambient to vapour phase liquid nitrogen. In May of this year, Biofortuna acquired Cryoniss providing the opportunity for Cryoniss to accelerate its growth as a world leading service provider.
Having handed over the corporate reins to Biofortuna’s highly experienced senior management team, my new role is Business Manager – Controlled Environment Storage. This means that I can focus my time on the fun parts of the business, talking to customers about their latest scientific endeavours, and working with our operations team to continue to deliver a world class storage service, this time with enhanced capabilities, including ICH Stability Storage services.
What do you enjoy most about your role?
The best part of my role by far is speaking to customers about their research. When I started working as a scientist post-graduation, drug-discovery was very much a handle-turning process. I was a cog supporting the discovery of kinases from High Throughput Screening lead generation activities. However, as the druggable kinome became saturated, science had to become smarter, hence, the outsourcing, and consequent internal de-risking by large pharma, of early-stage novel therapeutics. Working in a therapy-agnostic services company like Biofortuna, I talk to researchers and clinicians daily, who are working on some of the most exciting and novel scientific advancements. It is great to play a small part in their journey by supporting them however we can.
JOIN THE TEAM
We are a growing company committed to establishing ourselves as one of the world’s leading contract assay developers and manufacturers.
As a direct result of that growth, we are always on the lookout to expand our team with the brightest talent.
Click here to visit our careers page and view our latest opportunities.



